These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23254637)

  • 21. The impact of comorbid depression-diabetes on proteomic outcomes among community-dwelling Mexican Americans with mild cognitive impairment.
    Johnson LA; Zhang F; Large S; Hall J; O'Bryant SE
    Int Psychogeriatr; 2020 Jan; 32(1):17-23. PubMed ID: 31658917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Community-Based Study of Dementia in Mexican American and Non-Hispanic White Individuals.
    Morgenstern LB; Briceño EM; Mehdipanah R; Chang W; Lewandowski-Romps L; Gonzales XF; Levine DA; Langa KM; Garcia N; Khan N; Zahuranec DB; Heeringa SG
    J Alzheimers Dis; 2024; 97(2):649-658. PubMed ID: 38143352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer's dementia.
    Zhao A; Li Y; Yan Y; Qiu Y; Li B; Xu W; Wang Y; Liu J; Deng Y
    Transl Neurodegener; 2020 Aug; 9(1):30. PubMed ID: 32741361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C-reactive protein as a predictor of mild cognitive impairment conversion into Alzheimer's disease dementia.
    Fernandes A; Tábuas-Pereira M; Duro D; Lima M; Gens H; Santiago B; Durães J; Almeida MR; Leitão MJ; Baldeiras I; Santana I
    Exp Gerontol; 2020 Sep; 138():111004. PubMed ID: 32561398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using Fractional Anisotropy Imaging to Detect Mild Cognitive Impairment and Alzheimer's Disease among Mexican Americans and Non-Hispanic Whites: A HABLE Study.
    Hall JR; Johnson LA; Zhang F; Petersen M; Toga AW; Shi Y; Mason D; Rissman RA; Yaffe K; O'Bryant SE;
    Dement Geriatr Cogn Disord; 2021; 50(3):266-273. PubMed ID: 34569492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Depressive Endophenotype for Predicting Cognitive Decline among Mexican American Adults and Elders.
    Johnson LA; Gamboa A; Vintimilla R; Edwards M; Hall J; Weiser B; Yadav M; Dickensheets T; O'Bryant SE
    J Alzheimers Dis; 2016 Jul; 54(1):201-6. PubMed ID: 27472872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cross-Ethnic Differences in the Severity of Neuropsychiatric Symptoms in Persons With Mild Cognitive Impairment and Alzheimer's Disease.
    Salazar R; Dwivedi AK; Royall DR
    J Neuropsychiatry Clin Neurosci; 2017; 29(1):13-21. PubMed ID: 27417070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum Phosphatidylethanolamine and Lysophosphatidylethanolamine Levels Differentiate Alzheimer's Disease from Controls and Predict Progression from Mild Cognitive Impairment.
    Llano DA; Devanarayan V;
    J Alzheimers Dis; 2021; 80(1):311-319. PubMed ID: 33523012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population-Based Mini-Mental State Examination Norms in Adults of Mexican Heritage in the Cameron County Hispanic Cohort.
    Bukhbinder AS; Hinojosa M; Harris K; Li X; Farrell CM; Shyer M; Goodwin N; Anjum S; Hasan O; Cooper S; Sciba L; Vargas AF; Hunter DH; Ortiz GJ; Chung K; Cui L; Zhang GQ; Fisher-Hoch SP; McCormick JB; Schulz PE
    J Alzheimers Dis; 2023; 92(4):1323-1339. PubMed ID: 36872776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular markers of amnestic mild cognitive impairment among Mexican Americans.
    Edwards M; Hall J; Williams B; Johnson L; O'Bryant S
    J Alzheimers Dis; 2016; 49(1):221-8. PubMed ID: 26444793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypermethylation at CREBBP Is Associated with Cognitive Impairment in a Mexican American Cohort.
    Abraham Daniel A; Silzer T; Sun J; Zhou Z; Hall C; Phillips N; Barber R
    J Alzheimers Dis; 2023; 92(4):1229-1239. PubMed ID: 36872777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. δ Scores Identify Subsets of "Mild Cognitive Impairment" with Variable Conversion Risks.
    Royall DR; Palmer RF
    J Alzheimers Dis; 2019; 70(1):199-210. PubMed ID: 31127788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination of Plasma Neurofilament Light Chain and Mini-Mental State Examination Score Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease within 5 Years.
    Darmanthé N; Tabatabaei-Jafari H; Cherbuin N;
    J Alzheimers Dis; 2021; 82(3):951-964. PubMed ID: 34120902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral Markers of Vascular Endothelial Dysfunction Show Independent but Additive Relationships with Brain-Based Biomarkers in Association with Functional Impairment in Alzheimer's Disease.
    Drake JD; Chambers AB; Ott BR; Daiello LA;
    J Alzheimers Dis; 2021; 80(4):1553-1565. PubMed ID: 33720880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum Tau Proteins as Potential Biomarkers for the Assessment of Alzheimer's Disease Progression.
    Nam E; Lee YB; Moon C; Chang KA
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32679907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of inflammatory and hemostatic biomarkers in Alzheimer's and vascular dementia - A pilot study from a tertiary center in Northern India.
    Vishnu VY; Modi M; Garg VK; Mohanty M; Goyal MK; Lal V; Mittal BR; Prabhakar S
    Asian J Psychiatr; 2017 Oct; 29():59-62. PubMed ID: 29061429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia.
    Davis M; O Connell T; Johnson S; Cline S; Merikle E; Martenyi F; Simpson K
    Curr Alzheimer Res; 2018; 15(8):777-788. PubMed ID: 29357799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association Between Cognitive Impairment and Chronic Kidney Disease in Mexican Americans.
    Szerlip HM; Edwards ML; Williams BJ; Johnson LA; Vintimilla RM; O'Bryant SE
    J Am Geriatr Soc; 2015 Oct; 63(10):2023-8. PubMed ID: 26456700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteomics based identification of differential plasma proteins and changes in white matter integrity as markers in early detection of mild cognitive impaired subjects at high risk of Alzheimer's disease.
    Kumar A; Singh S; Verma A; Mishra VN
    Neurosci Lett; 2018 May; 676():71-77. PubMed ID: 29649488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.